Personal information

No personal information available

Activities

Collapse all

Works (33)

Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism.

Journal of bone and mineral metabolism
2020-11 | Journal article
DOI: 10.1007/s00774-020-01169-z
PMID: 33196900
Contributors: Hayashi N; Imanishi Y; Hirakawa T; Kobayashi I; Tateishi T; Miyaoka D; Nagata Y; Mori K; Morioka T; Inoue A et al.
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Effect of etelcalcetide on parathyroid hormone secretion by primary hyperparathyroidism patient-derived primary parathyroid cells.

Journal of bone and mineral metabolism
2020-10 | Journal article
DOI: 10.1007/s00774-020-01158-2
PMID: 33047189
Contributors: Fujioka A; Imanishi Y; Kobayashi I; Hirakawa T; Inoue A; Harada K; Taguchi M; Sugiura Y; Yamada H; Miyaoka D et al.
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Pharmacology of Parsabiv® (etelcalcetide, ONO-5163/AMG 416), a novel allosteric modulator of the calcium-sensing receptor, for secondary hyperparathyroidism in hemodialysis patients.

European journal of pharmacology
2018-10 | Journal article
DOI: 10.1016/j.ejphar.2018.10.021
PMID: 30342948
Contributors: Harada K; Fujioka A; Konno M; Inoue A; Yamada H; Hirota Y
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

[The Discovery, Research and Development of Etelcalcetide Hydrochloride, the World 1st Intravenous Calcimimetics.]

2017 | Journal article
DOI:

clica1704537545

PMID: 28336830
Contributors: Inoue A; Harada K
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

The pharmacological profile and the clinical efficacy of the world's 1st intravenous calcimimetics; etelcalcetide hydrochloride (Parsabiv®).

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
2017 | Journal article
DOI: 10.1254/fpj.150.98
PMID: 28794306
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Comparative study of the zebrafish embryonic toxicity test and mouse embryonic stem cell test to screen developmental toxicity of human pharmaceutical drugs

Fundam. Toxicol. Sci.
2016 | Journal article
DOI: 10.2131/fts.3.79
Contributors: Atsuto Inoue; Yuhei Nishimura; Norihito Matsumoto; Noriko Umemoto; Yasuhito Shimada; Toru Maruyama; Kana Kayasuga; Motohiko Morihara; Jun Katagi; Tsutomu Shiroya et al.
Source: Self-asserted source
Atsuto Inoue via Crossref Metadata Search

Abnormal spermatogenesis and male infertility in testicular zinc finger protein Zfp318-knockout mice.

2016-07 | Journal article
DOI: 10.1111/dgd.12301
PMID: 27385512
Contributors: Ishizuka M; Ohtsuka E; Inoue A; Odaka M; Ohshima H; Tamura N; Yoshida K; Sako N; Baba T; Kashiwabara SI et al.
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Using zebrafish in systems toxicology for developmental toxicity testing.

2016-01 | Journal article
DOI: 10.1111/cga.12142
PMID: 26537640
Contributors: Nishimura Y; Inoue A; Sasagawa S; Koiwa J; Kawaguchi K; Kawase R; Maruyama T; Kim S; Tanaka T
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.

2015-10 | Journal article
DOI: 10.1016/j.ejphar.2015.08.041
PMID: 26318198
Contributors: Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; inoue A; Nakao T; Nomura H; Murata M; Nakao S et al.
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

2015-08 | Journal article
DOI: 10.1021/acs.jmedchem.5b00741
PMID: 26200813
Contributors: Itadani S; Yashiro K; Aratani Y; Sekiguchi T; Kinoshita A; Moriguchi H; Ohta N; Takahashi S; Ishida A; Tajima Y et al.
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Discovery of a potent, orally available dual CysLT1 and CysLT2 antagonist with dicarboxylic acid

Bioorganic & Medicinal Chemistry
2015-05 | Journal article
DOI: 10.1016/j.bmc.2015.03.011
Contributors: Satoshi Itadani; Shinya Takahashi; Masaki Ima; Tetsuya Sekiguchi; Yoshiyuki Aratani; Hiromu Egashira; Naoya Matsumura; Atsuto Inoue; Yasuo Yonetomi; Manabu Fujita et al.
Source: check_circle
Crossref

Testicular zinc finger protein recruits histone deacetylase 2 and suppresses the transactivation function and intranuclear foci formation of agonist-bound androgen receptor competitively with TIF2.

2006-03 | Journal article
DOI: 10.1016/j.mce.2005.12.052
PMID: 16469430
Contributors: Tao RH; Kawate H; Wu Y; Ohnaka K; Ishizuka M; Inoue A; Hagiwara H; Takayanagi R
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Molecular cloning and characteristics of a novel zinc finger protein and its splice variant whose transcripts are expressed during spermatogenesis.

2003-02 | Journal article
DOI: 10.1016/S0006-291X(03)00085-8
PMID: 12589823
Contributors: Ishizuka M; Ohshima H; Tamura N; Nakada T; Inoue A; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central
grade
Preferred source (of 2)‎

Identification of a novel osteoblastic gene, inducible by C-type natriuretic peptide, whose transcript might function in mineralization as a noncoding RNA.

2002-02 | Journal article
DOI: 10.1007/s00223-001-1012-3
PMID: 11870417
Contributors: Inoue A; Kobayashi Y; Ishizuka M; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Vasoactive Peptide-Regulated Gene Expression During Osteoblastic Differentiation

Journal of Cardiovascular Pharmacology
2000 | Journal article
DOI: 10.1097/00005344-200036001-00084
Contributors: Atsuto Inoue; Asako Kamiya; Atsushi Ishiji; Yoshiharu Hiruma; Shigehisa Hirose; Hiromi Hagiwara
Source: Self-asserted source
Atsuto Inoue via Crossref Metadata Search

Vasoactive peptide-regulated gene expression during osteoblastic differentiation.

2000-11 | Journal article
DOI: 10.1097/00005344-200036051-00084
PMID: 11078400
Contributors: Inoue A; Kamiya A; Ishiji A; Hiruma Y; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

The transcript for a novel protein with a zinc finger motif is expressed at specific stages of mouse spermatogenesis.

2000-07 | Journal article
DOI: 10.1006/bbrc.2000.2953
PMID: 10873617
Contributors: Inoue A; Ishiji A; Kasagi S; Ishizuka M; Hirose S; Baba T; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E(2).

2000-03 | Journal article
DOI: 10.1016/S0014-2999(00)00100-X
PMID: 10729362
Contributors: Koyama A; Otsuka E; Inoue A; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central
grade
Preferred source (of 2)‎

Concentration of mRNA for the natriuretic peptide receptor-C in hypertrophic chondrocytes of the fetal mouse tibia.

2000-02 | Journal article
DOI: 10.1093/oxfordjournals.jbchem.a022591
PMID: 10731681
Contributors: Yamashita Y; Takeshige K; Inoue A; Hirose S; Takamori A; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone.

1999-11 | Journal article
DOI: 10.1016/S0014-2999(99)00551-8
PMID: 10594333
Contributors: Yuhara S; Kasagi S; Inoue A; Otsuka E; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central
grade
Preferred source (of 2)‎

Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells.

1999-07 | Journal article
DOI: 10.1093/oxfordjournals.jbchem.a022418
PMID: 10393335
Contributors: Hagiwara H; Naruse M; Adachi C; Inoue A; Hiruma Y; Otsuka E; Naruse K; Demura H; Hirose S
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells.

1999-01 | Journal article
DOI: 10.1093/oxfordjournals.jbchem.a022245
PMID: 9880804
Contributors: Inoue A; Hayakawa T; Otsuka E; Kamiya A; Suzuki Y; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Endothelins inhibit mineralization of rat calvarial osteoblast-like cells.

1998 | Journal article
DOI: 10.1097/00005344-199800001-00150
PMID: 9595531
Contributors: Hiruma Y; Inoue A; Shiohama A; Otsuka E; Hirose S; Yamaguchi A; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Endothelins inhibit the mineralization of osteoblastic MC3T3-E1 cells through the A-type endothelin receptor.

1998-10 | Journal article
PMID: 9756539
Contributors: Hiruma Y; Inoue A; Shiohama A; Otsuka E; Hirose S; Yamaguchi A; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism.

1998-05 | Journal article
DOI: 10.1016/S0014-2999(98)00190-3
PMID: 9671116
Contributors: Otsuka E; Hirano K; Matsushita S; Inoue A; Hirose S; Yamaguchi A; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central
grade
Preferred source (of 2)‎

Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells.

1998-03 | Journal article
DOI: 10.1677/joe.0.1560543
PMID: 9582511
Contributors: Hagiwara H; Hiruma Y; Inoue A; Yamaguchi A; Hirose S
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae.

1997-01 | Journal article
DOI: 10.1006/bbrc.1996.5914
PMID: 9020040
Contributors: Hiruma Y; Inoue A; Hirose S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Stimulation by retinoids of the natriuretic peptide system of osteoblastic MC3T3-E1 cells.

1996-11 | Journal article
DOI: 10.1006/bbrc.1996.1636
PMID: 8912656
Contributors: Inoue A; Otsuka E; Hiruma Y; Hirose S; Furuya M; Tanaka S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells.

1996-05 | Journal article
PMID: 8967430
Contributors: Hagiwara H; Inoue A; Yamaguchi A; Yokose S; Furuya M; Tanaka S; Hirose S
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Inhibition of proliferation of chondrocytes by specific receptors in response to retinoids.

1996-05 | Journal article
DOI: 10.1006/bbrc.1996.0725
PMID: 8670186
Contributors: Hagiwara H; Inoue A; Nakajo S; Nakaya K; Kojima S; Hirose S
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells.

1996-04 | Journal article
DOI: 10.1006/bbrc.1996.0660
PMID: 8630025
Contributors: Inoue A; Hiruma Y; Hirose S; Yamaguchi A; Furuya M; Tanaka S; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Change in the expression of C-type natriuretic peptide and its receptor, B-type natriuretic peptide receptor, during dedifferentiation of chondrocytes into fibroblast-like cells.

1996-02 | Journal article
DOI: 10.1093/oxfordjournals.jbchem.a021233
PMID: 8882716
Contributors: Hagiwara H; Inoue A; Furuya M; Tanaka S; Hirose S
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central

Reciprocal regulation by cyclic nucleotides of the differentiation of rat osteoblast-like cells and mineralization of nodules.

1995-10 | Journal article
DOI: 10.1006/bbrc.1995.2577
PMID: 7488037
Contributors: Inoue A; Hiruma Y; Hirose S; Yamaguchi A; Hagiwara H
Source: Self-asserted source
Atsuto Inoue via Europe PubMed Central
How many people are using ORCID?